Retinal imaging is a technique that is used to analyze and diagnose the condition of a patient's retina. Retinal imaging devices (RID) use high-resolution imaging systems to capture inside pictures of an eye. The captured image helps Virtual Private Network (VSP) network doctors assess the health of the retina, which helps in the detection and management of eye and health conditions such as diabetes, glaucoma, and macular degeneration, amongst others.
The growth of the retinal imaging devices market is attributed to the improved ophthalmologists’ access to the retina, growing global initiatives for blindness and technological advancements. However, the high cost of OCT devices hampers the market growth.
Retinal imaging devices are widely used to diagnose and treat various eye-related diseases such as diabetic retinopathy, age-related macular degeneration, glaucoma, ocular melanoma, and mild vision problems. In addition, across the world, concern for blindness or vision impairment is growing significantly. According to the data published by the World Health Organization (WHO) in October 2021, nearly 2.2 billion people live with a vision impairment or blindness. Among which approximately one billion vision impairment cases can be prevented by proper diagnosis and treatment. These one billion people have different eye problems related to moderate or severe distance vision impairment or blindness. Image-related diagnostic technologies have begun to offer unprecedented growth into eye diseases based on morphological datasets. Such a factor is expected to aid the retinal imaging devices market over the forecast period.
Based on device type, the global retinal imaging devices market has been segmented into fluorescein angiography, fundus camera, and optical coherence tomography. The fundus camera segment held the largest share of the market in 2021. Fundus photography has transformed from electronic flashes to smartphone-based cameras to a more recent portable eye examination kit (PEEK). PEEK is a smartphone-based application for a comprehensive eye examination. The advantage of these cameras is that a non-ophthalmologist can take pictures and, with some training, grade them as well. However, the optical coherence tomography segment is anticipated to register the highest CAGR of 8.1% in the market during the forecast period. The optical coherence tomography allows the evaluation of different levels of macular ischemia that are not diagnosed in primary imaging. The technique is used as a standard for imaging modalities for eyes.
Based on end-user, the global retinal imaging devices market is segmented into hospitals and clinics, specialty clinics, ambulatory care centers, and others. The hospitals & clinics segment held the largest share of the market in 2021 and specialized eye care centers is expected to register the highest CAGR of 6.6% in the market during the forecast period.
The regional trends and factors influencing the Retinal Imaging Devices Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Retinal Imaging Devices Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 2.06 Billion |
Market Size by 2028 | US$ 3 Billion |
Global CAGR (2021 - 2028) | 5.6% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Device Type
|
Regions and Countries Covered | North America
|
Market leaders and key company profiles |
The Retinal Imaging Devices Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.
Major Companies operating in the Retinal Imaging Devices Market are:
Disclaimer: The companies listed above are not ranked in any particular order.
Based on regions, the North America region accounted for the largest share in 2021 and is expected to follow a similar trend over the forecast period. The Asia Pacific region is expected to witness the highest growth rate over the forecast period. The application of Artificial intelligence (AI) and deep learning system (DLS) to improve screening coverage in Singapore is expected to assist the regional growth over the next seven years.
Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the retinal imaging devices market players focus on the partnership strategy to expand their clientele, which, in turn, permits them to maintain their brand name across the world.
Based on device type, the retinal imaging devices market is categorized into fluorescein angiography, fundus camera and optical coherence tomography. Based on end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers, specialized eye care centers and other end users. By geography, the retinal imaging devices market is segmented into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific), the Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa), and South and Central America (Brazil, Argentina, and the Rest of South and Central America).Some of the company profiles listed in our research scope are Carl Zeiss Meditec, Revenio Group Oyj, Nikon Corporation, Optomed, Topcon Corporation, Imagine Eyes, Epipole Ltd, Forus Health Pvt Ltd, Eyenuk Inc, and Phoenix Technology Group LLC amongst others.
The global retinal imaging devices market is expected to reach US$ 3,009.55 million by 2028 from US$ 2,060.01 million in 2021; it is estimated to grow at a CAGR of 5.6% during 2021–2028.
The retinal imaging devices market majorly consists of players such as Carl Zeiss Meditec, Revenio Group Oyj, Nikon Corporation, Optomed, Topcon Corporation, Imagine Eyes, Epipole Ltd, Forus Health Pvt Ltd, Eyenuk Inc, and Phoenix Technology Group LLC among others.
The fundus camera type held the largest share of the market in 2021. However, the optical coherence tomography type is anticipated to register the highest CAGR of 8.1% in the market during the forecast period. The optical coherence tomography allows the evaluation of different levels of macular ischemia that are not diagnosed in primary imaging. The technique is used as a standard for imaging modalities for eyes.
The Asia Pacific registered as the fastest-growing region in the global retinal imaging devices market. The market in this region is expected to grow significantly in countries such as China, Japan, and India. The market is driven by the rising prevalence of eye diseases and related factors. In China, eye diseases such as uncorrected sight problems, limited access to ophthalmologists in rural parts are driving the market growth. Whereas in Japan, the cost of eye health is rising significantly, and in India, the prevalence of diabetic retinopathy is growing exponentially. Also, factors such as the rising geriatric population in South Korea and global initiatives such as Vision 2020 in Australia are likely to support the growth of the market during the forecast period
The growth of the market is attributed to the rising prevalence of eye diseases, growing global initiatives for blindness and technological advancement in ophthalmology drives the market growth. However, the high cost of OCT devices hampers the market growth.